ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,194, issued on July 29, was assigned to Eikonizo Therapeutics Inc. (Cambridge, Mass.).
"Metalloenzyme inhibitor compounds" was invented by Christopher M. Yates (Belmont, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6."
The patent was filed on Feb. 16, 2024, under Application No. 18/443,509.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=1...